• OPEN AN ACCOUNT
Indian Indices
Nifty
24,812.05 -41.35
(-0.17%)
Sensex
81,405.19 -39.47
( -0.05%)
Bank Nifty
55,828.75 114.60
( 0.21%)
Nifty IT
39,030.90 -325.20
( -0.83%)
Global Indices
Nasdaq
42,197.27 -39.54
(-0.09%)
Dow Jones
6,001.75 -1.97
(-0.03%)
Hang Seng
38,827.31 290.57
(0.75%)
Nikkei 225
8,843.47 9.44
(0.11%)
Forex
USD-INR
86.25 0.22
(0.26%)
EUR-INR
99.47 -0.03
(-0.03%)
GBP-INR
116.59 -0.20
(-0.17%)
JPY-INR
0.59 0.00
(-0.18%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
56.2513194
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
36.88
3775.43
EPS(TTM)
Face Value()
Div & Yield %
9.15
2
1.54
 

aplab ltd
Timken India standalone net profit rises 32.10% in the March 2025 quarter
May 24,2025
Net profit of Timken India rose 32.10% to Rs 186.83 crore in the quarter ended March 2025 as against Rs 141.43 crore during the previous quarter ended March 2024. Sales rose 4.68% to Rs 939.79 crore in the quarter ended March 2025 as against Rs 897.77 crore during the previous quarter ended March 2024.

For the full year,net profit rose 14.09% to Rs 447.39 crore in the year ended March 2025 as against Rs 392.14 crore during the previous year ended March 2024. Sales rose 8.19% to Rs 3147.81 crore in the year ended March 2025 as against Rs 2909.54 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales939.79897.77 5 3147.812909.54 8
OPM %22.3222.13 -18.7919.67 -
PBDT222.40208.33 7 637.50609.39 5
PBT201.53186.55 8 552.73524.22 5
NP186.83141.43 32 447.39392.14 14